LIVZON PHARMA (01513) announced quarterly results: 2026年第三季度報告, net profit attributable to owners RMB9322000.0bn Title: 2026年第三季度報告 Revenue: RMB50.0bn Profit attributable to owners: RMB9322000.0bn